Block Copolymer Nanoparticles for Multi-miRNA Lung Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene delivery systems, including adeno-associated viruses (AAVs) and non-viral systems like liposomes, face challenges in efficiently delivering multiple genetic payloads, such as small non-coding microRNAs, to specific tissues while avoiding off-target effects and immune responses, particularly in lung cancer therapy, where they are limited by poor biocompatibility and degradation.
Innovation Solution
Development of block copolymers that self-assemble into polymer nanoparticles (PNPs) capable of complexing multiple nucleic acids, including miRNAs, to effectively target and deliver them to lung cancer cells, enhancing transfection efficiency and reducing toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If adeno-associated viruses (AAVs) are used for gene delivery, then delivery efficiency to specific tissues is improved, but immune responses and inability to deliver multiple payloads simultaneously occur
Solution Approach 1:
The patent replaces persistent viral vectors (AAVs) with transient polymer-based nanoparticles that do not trigger long-term immune responses. These disposable-like polymeric carriers can be synthesized, used for delivery, and eliminated without causing persistent immunogenicity, thus resolving the immune response issue while maintaining delivery functionality
Solution Approach 2:
The patent designs a universal polymeric nanoparticle platform that can deliver multiple different genetic payloads (miRNAs, siRNAs, DNA, mRNA) simultaneously through a single carrier system. This multi-functional platform eliminates the need for different viral vectors for different payloads, solving both the immune response problem and the limitation of single-payload delivery
2Object-generated harmful factors
If liposomes are used as non-viral gene delivery systems, then immune responses are reduced, but biocompatibility and payload packaging capability deteriorate
Solution Approach 1:
The patent employs block copolymers composed of hydrophobic and hydrophilic segments that self-assemble into nanoparticles with optimized biocompatibility. The hydrophilic blocks (e.g., PEG) provide stealth properties and reduced immune recognition, while the hydrophobic blocks enable effective packaging of genetic payloads, thus improving upon liposome limitations in both biocompatibility and packaging capability
Solution Approach 2:
The patent systematically varies polymer composition, molecular weight, and block ratios to optimize nanoparticle properties for enhanced biocompatibility and payload capacity. By adjusting these parameters, the system achieves superior performance compared to liposomes in terms of both biocompatibility and ability to package large genetic payloads
3Object-generated harmful factors
If current non-viral delivery systems are used, then immune responses are avoided, but degradation by enzymes and poor packaging of multiple large payloads occur
Solution Approach 1:
The patent modifies polymer chemical structure, incorporating enzymatically resistant bonds and steric protection groups that prevent nuclease degradation. The block copolymer design includes protective hydrophilic blocks that shield the genetic payload from enzymatic attack while maintaining stability in biological environments, thus resolving the degradation issue without compromising the low immunogenicity advantage
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PNPs achieve significant transfection efficiency, with up to 100-fold increase in miRNA expression, improved wound closure in lung cells, and potential for combinatorial therapies, demonstrating enhanced delivery and therapeutic efficacy.
Implementation Method 1
Development of block copolymers that self-assemble into polymer nanoparticles (PNPs) capable of complexing multiple nucleic acids
Implementation Method 2
polymer nanoparticles (PNPs) capable of complexing multiple nucleic acids
Data Source
AI summary
The disclosure relates to block copolymer nanoparticles for therapeutic delivery of nucleotides, and methods therefor. More particularly, the invention relates to polymer nanoparticles, such as reversible addition-fragmentation chain transfer (RAFT) polymer compositions, for delivering miRNAs.